Skip to Main Content

Advertisement

Skip Nav Destination

Disease Stage Variation in CD4+ and CD8+ T-Cell Reactivity to the Receptor Tyrosine Kinase EphA2 in Patients with Renal Cell Carcinoma1

Cancer Res (2003) 63 (15): 4481–4489.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal